Zenox, you had better hope that RedHill's strategy is better than their maths.
The percentages quoted in their latest press release do not compute, unless you exclude deaths from the equation. If this is the case, why not state the number of deaths up front?
When implied deaths are included, the treatment arm is still superior to the control arm, but their exclusion seems to have left a sour taste with investors. RDHL closed DOWN 5.6% in the USA after the Phase 2 results were released.
Competitors, page-10
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.04M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 72463 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 8810 | 1 |
View Market Depth
| Last trade - 10.16am 29/07/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable